financetom
Business
financetom
/
Business
/
Lucid Wins Nikola Bankruptcy Auction, Buys Nikola Facilities for $30 Million To Boost US EV Production
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lucid Wins Nikola Bankruptcy Auction, Buys Nikola Facilities for $30 Million To Boost US EV Production
Apr 11, 2025 3:54 AM

Lucid Group, Inc ( LCID ) announced Friday that it has agreed to acquire select facilities and assets in Arizona previously belonging to Nikola Corp ( NKLAQ ) in the bankruptcy auction.

Lucid committed close to $30 million in cash and non-cash considerations in exchange for the factory, Nikola's ( NKLAQ ) lease on its Phoenix headquarters, and "certain machinery, equipment and inventory," as per a Thursday night court filing.

Tesla Inc ( TSLA ) rival Lucid will take over Nikola's ( NKLAQ ) former Coolidge manufacturing facility (680 E Houser Rd, Coolidge, AZ) and the Phoenix facility (4141 E Broadway Rd, Phoenix, AZ) previously used as Nikola's ( NKLAQ ) headquarters and product development center.

Also Read: Nio Power In Deal Talks With Tesla Battery Supplier CATL

These buildings add more than 884,000 square feet to Lucid's Arizona footprint. Most of this space comprises state-of-the-art manufacturing and warehousing buildings, which executes against Lucid's prior planned expansion in Arizona.

These facilities include development equipment with extensive battery and environmental testing chambers, a full-size chassis dynamometer, machining equipment, and more.

The deal is subject to approval by the U.S. Bankruptcy Court for the District of Delaware.

The deal does not include acquiring Nikola's ( NKLAQ ) business, customer base, or technology related to Nikola's ( NKLAQ ) hydrogen fuel cell electric trucks.

Additionally, Lucid plans to offer employment to more than 300 former Nikola employees in roles across Lucid's Arizona facilities.

These offers will encompass various technical salaried and hourly positions, including manufacturing engineering, software, assembly, vehicle testing, and warehouse support. Lucid welcomes employees with strong backgrounds in EV technology and further supports its local community.

Nikola's ( NKLAQ ) bankruptcy auction concluded on April 10, 2025, as part of its filing for Chapter 11 bankruptcy relief. Nikola's ( NKLAQ ) troubles began back in 2020 when short-seller Hindenburg accused it of fraud, followed by the conviction of former CEO Trevor Milton for lying about the company.

Hindenburg highlighted Nikola's ( NKLAQ ) video titled "Nikola One in Motion," alleging that the company towed the truck to the top of a hill and released it instead of being driven at high speed. 

In December 2023Milton was convicted of fraud after a jury found he had lied persistently about the company. The subsequent investigation led to Milton's conviction on fraud charges in 2022 and a four-year prison sentence.

In April 2024, Milton alleged Nikola's ( NKLAQ ) board of rampant misconduct and potential fraud. He also sought the resignation of then-CEO Steve Girsky and those involved in their decisions, as failing to do so might make the company go bankrupt by year-end.

In June 2024, Milton filed a multi-billion derivative lawsuit against the company's chief legal officer, Britton Worthen, and its directors.

Reportedly, electric vehicle companies that went public during the pandemic, including Fisker, Lordstown Motors, and Proterra, went bankrupt as funding for their operations declined amid rising interest rates and decreasing demand.

Last week, Lucid announced the pricing of its private institutional offering of $1 billion aggregate principal amount of 5.00% convertible senior notes due 2030 for buyback of earlier debt due in 2026.

Lucid held $1.61 billion in cash and equivalents as of December 31, 2024.

Price Action: LCID stock is up 1.59% at $2.56 premarket at last check Friday.

Read Next:

Foxconn Eyes Nissan, Mitsubishi In Japan EV Push To Counter China's Growing Auto Threat

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved